A Phase IV Open Label Randomized Multicenter Comparative Study Of Celecoxib Efficacy And Safety Versus Standard Doses Of Oral Diclofenac In Acute Pain Due To Cervical Sprain Related To Motor Vehicle Accident.

Trial Profile

A Phase IV Open Label Randomized Multicenter Comparative Study Of Celecoxib Efficacy And Safety Versus Standard Doses Of Oral Diclofenac In Acute Pain Due To Cervical Sprain Related To Motor Vehicle Accident.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 28 Feb 2011

At a glance

  • Drugs Celecoxib; Diclofenac
  • Indications Acute pain
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 24 Feb 2011 Actual end date (Jan 2010) added as reported by ClinicalTrials.gov.
    • 24 Feb 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 08 Sep 2010 Planned end date changed from 1 Feb 2011 to 1 Jun 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top